Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CABAZITAXEL vs CABOZANTINIB S-MALATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CABAZITAXEL vs CABOZANTINIB S-MALATE: Safety Overview

Metric CABAZITAXEL CABOZANTINIB S-MALATE
Total FAERS Reports 2,553 39,270
Deaths Reported 467 4,203
Death Rate 18.3% 10.7%
Hospitalizations 950 6,193
Average Patient Age 68.7 yrs 65.0 yrs
% Female Patients 2.0% 29.9%
FDA Approval Date Dec 29, 2021 Apr 25, 2016
Manufacturer Sanofi-Aventis U.S. LLC Exelixis, Inc.
Route N/A ORAL
Marketing Status Prescription Prescription